We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical Invests in Paint Protection Film Patterns
Read MoreHide Full Article
Eastman Chemical Company’s (EMN - Free Report) Performance Films, LLC — a part of its Advanced Materials business segment — made an investment in leading 3D scanning technology for paint protection film patterns.
The next-generation enhancement will help to transform the process of pattern development. The technology will help to achieve previously unattainable levels of accuracy and speed.
Deployment of 3D scanning technology is expected to rapidly uplift the company’s current database of paint protection film patterns. Moreover, the rate of trim additions and new model to the database will be accelerated with better-quality precision.
The innovative 3D scanning technology employs lasers to capture the shape of any vehicle as flexible data. Eastman Chemical’s latest move highlights commitment to develop world-class paint protection film offering.
Eastman Chemical’s shares have lost 33.5% in the past year compared with 32.8% decline of the industry.
The company delivered adjusted earnings per share (EPS) of $1.77 in the first quarter, down from $2.23 in the year ago-quarter. The figure also trailed the Zacks Consensus Estimate of $1.91.
Eastman Chemical expects strong earnings growth in the second quarter on a sequential comparison basis. However, the company expects the difficult global business environment to continue through first-half 2019.
It is undertaking additional cost reduction actions in the wake of a challenging business environment. The company expects global economy to strengthen in the second half of 2019. The company continues to expect adjusted EPS growth of 6-10% in 2019.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Materion has an expected earnings growth rate of 23.1% for 2019. The company’s shares have gained 18.2% in the past year.
Fortescue Metals has an expected earnings growth rate of 101.5% for the current year. The company’s shares have surged 58.9% in a year’s time.
AngloGold has an expected earnings growth rate of 86.8% for 2019. Its shares have rallied 38.1% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Eastman Chemical Invests in Paint Protection Film Patterns
Eastman Chemical Company’s (EMN - Free Report) Performance Films, LLC — a part of its Advanced Materials business segment — made an investment in leading 3D scanning technology for paint protection film patterns.
The next-generation enhancement will help to transform the process of pattern development. The technology will help to achieve previously unattainable levels of accuracy and speed.
Deployment of 3D scanning technology is expected to rapidly uplift the company’s current database of paint protection film patterns. Moreover, the rate of trim additions and new model to the database will be accelerated with better-quality precision.
The innovative 3D scanning technology employs lasers to capture the shape of any vehicle as flexible data. Eastman Chemical’s latest move highlights commitment to develop world-class paint protection film offering.
Eastman Chemical’s shares have lost 33.5% in the past year compared with 32.8% decline of the industry.
The company delivered adjusted earnings per share (EPS) of $1.77 in the first quarter, down from $2.23 in the year ago-quarter. The figure also trailed the Zacks Consensus Estimate of $1.91.
Eastman Chemical expects strong earnings growth in the second quarter on a sequential comparison basis. However, the company expects the difficult global business environment to continue through first-half 2019.
It is undertaking additional cost reduction actions in the wake of a challenging business environment. The company expects global economy to strengthen in the second half of 2019. The company continues to expect adjusted EPS growth of 6-10% in 2019.
Zacks Rank & Key Picks
Eastman Chemical currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the basic materials space are Materion Corporation (MTRN - Free Report) , Fortescue Metals Group Ltd. (FSUGY - Free Report) and AngloGold Ashanti Limited (AU - Free Report) , all currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Materion has an expected earnings growth rate of 23.1% for 2019. The company’s shares have gained 18.2% in the past year.
Fortescue Metals has an expected earnings growth rate of 101.5% for the current year. The company’s shares have surged 58.9% in a year’s time.
AngloGold has an expected earnings growth rate of 86.8% for 2019. Its shares have rallied 38.1% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>